Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index.

Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma

Open access
Zhou, Jianbiao, Chng, Wee-Joo · 2022 · Cells

Abstract

Multiple myeloma (MM) is the second most common hematological malignancy, characterized by an abnormal accumulation of plasma cells in the bone marrow. Signal transducer and activator of transcription 3 (STAT3) is a cytoplasmic transcription factor that modulates the transcription of multiple genes to regulate various principal biological functions, for example, cell proliferation and survival, stemness, inflammation and immune responses. Aberrant STAT3 activation has been identified as a key driver of tumorigenesis in many types of cancers, including MM. Herein, we summarize the current evidence for the role of STAT3 in affecting cancer hallmark traits by: (1) sustaining MM cell survival and proliferation, (2) regulating tumor microenvironment, (3) inducing immunosuppression. We also provide an update of different strategies for targeting STAT3 in MM with special emphasis on JAK inhibitors that are currently undergoing clinical trials. Finally, we discuss the challenges and future direction of understanding STAT3 signaling in MM biology and the clinical development of STAT3 inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11060941

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Venn diagrams of genes upregulated in MM cell lines after additional IL-6 stimulation. The MM-STAT3 signature contains 15 upregulated genes shared by studies of Brocke-Heidrich K, et al. (B-H.K., ref. [21]) and Tsuyama N (T.N., ref. [22]).
Figure 1 Venn diagrams of genes upregulated in MM cell lines after additional IL-6 stimulation. The MM-STAT3 signature contains 15 upregulated genes shared by studies of Brocke-Heidrich K, et al. (B-H.K., ref. [21]) and Tsuyama N (T.N., ref. [22]).CC BY · PubMed Central
Figure 2 STAT3 regulates the biological hallmarks and enabling characteristics of multiple myeloma. The key mechanisms of action undertaken by STAT3 in facilitating the hallmarks: (1) sustaining MM cell survival and proliferation; (2) regulating tumor microenvironment (bone marrow niche); (3) inducing immunosuppression, and characteristic pathways and essential genes are listed. Genes or pathways in black font represent overexpression or activation, while gene and cell type and function with down arrows in blue font denote decreased expression, or number or function.
Figure 2 STAT3 regulates the biological hallmarks and enabling characteristics of multiple myeloma. The key mechanisms of action undertaken by STAT3 in facilitating the hallmarks: (1) sustaining MM cell survival and proliferation; (2) regulating tumor microenvironment (bone marrow niche); (3) inducing immunosuppression, and characteristic pathways and essential genes are listed. Genes or pathways in black font represent overexpression or activation, while gene and cell type and function with down arrows in blue font denote decreased expression, or number or function.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 22

Metadata

Authors
Zhou, J., & Chng, W.-J.
Affiliations
National University of Singapore (SG)
Corresponding author
Zhou, Jianbiao
Venue
Cells
Publisher
MDPI AG
Published
2022-03-10
Volume
11
Issue
6
Pages
941
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4220897706
Cited by
22
References
74
Citations by year
2026: 6 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 1
FWCI
0.71
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation
  • National University of Singapore
  • National Research Foundation Singapore
  • National Medical Research Council (CIRG19nov-0006)
  • Institute for Health Innovation and Technology, National University of Singapore
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
multiple myeloma, STAT3 signaling, cancer hallmarks, tumor microenvironment, immunosuppression, JAK inhibitors, STAT3 inhibitor, clinical trials, plasma cells
MeSH terms
Antineoplastic Agents, Humans, Multiple Myeloma, Signal Transduction, STAT3 Transcription Factor, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.